Management of the oral and maxillofacial surgery patient on anabolic steroids.
Recent Food and Drug Administration estimates indicate that the anabolic steroid market has reached the $100 million level. Although the news media report steroid-related deaths, there is little in the medical literature communicating the clinical implications concerning these drugs. Electrolyte disturbances, coagulopathies, hypertension, and dysrhythmias are a few of the potential side effects. The pharmacology and pathophysiology of anabolic steroids are presented with a discussion of the anesthetic and surgical concerns for the patient undergoing oral and maxillofacial surgery.